Trial Profile
Evaluation of topographical binding pattern of 18F-AV-1451 in patients with Alzheimer disease and behavioral variant frontotemporal dementia and study-matched healthy controls
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary) ; Florbenazine F18
- Indications Alzheimer's disease; Dementia
- Focus Diagnostic use
- 24 Aug 2017 New trial record
- 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017